5GZ — HGH Holdings Income Statement
0.000.00%
Last trade - 00:00- SG$28.49m
- SG$31.30m
- SG$21.32m
- 18
- 52
- 88
- 54
Annual income statement for HGH Holdings, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.7 | 20.1 | 21.6 | 20 | 21.3 |
| Cost of Revenue | |||||
| Gross Profit | 3.65 | 4.55 | 3.84 | 3.78 | 6.08 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.8 | 22.5 | 23.4 | 20.6 | 21.1 |
| Operating Profit | -4.1 | -2.39 | -1.8 | -0.566 | 0.237 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.81 | -3.02 | -1.78 | -0.606 | -0.332 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.25 | -2.29 | -1.51 | -0.324 | -0.233 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.24 | -2.27 | -1.5 | -0.307 | -0.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.24 | -2.27 | -1.5 | -0.307 | -0.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.001 | -0.001 | -0 | -0 |